Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study

Background: Androgen receptor (AR) expression has emerged as a potential prognostic and predictive marker in patients with triple negative breast cancer (TNBC). We conducted a retrospective analysis to evaluate pathologic complete response (pCR) rates, disease-free survival (DFS) and overall surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridhar, Nithya, Glisch, Chad, Jawa, Zeeshan, Chaudhary, Lubna N., Kamaraju, Sailaja, Burfeind, John, Charlson, John, Chitambar, Christopher R., Jorns, Julie M., Cheng, Yee Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174868/
https://www.ncbi.nlm.nih.gov/pubmed/35711833
http://dx.doi.org/10.7150/jca.67536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174868/
https://www.ncbi.nlm.nih.gov/pubmed/35711833
http://dx.doi.org/10.7150/jca.67536

Ejemplares similares